DBVT FY 2024 Earnings — DBV Technologies S.A. Revenue & Financial Results | Market Cap Arena

DBVTDBV Technologies S.A.

$560M

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

-$7M

Operating Income

-$121M

Net Income

-$114M

EPS (Diluted)

$-5.90

Cash Flow

Operating Cash Flow

-$104M

Free Cash Flow

-$107M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$66M

Total Liabilities

$38M

Stockholders' Equity

$27M

Cash & Equivalents

$32M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$16M	-100.0%
Gross Profit	-$7M	$16M	-143.3%
Operating Income	-$121M	-$76M	-57.7%
Net Income	-$114M	-$73M	-56.4%